Pfizer and BioNTech get positive results in phase 2/3 trial of COVID-19 Vax for children 5 to 11 years, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Trial results provide a strong foundation for seeking authorization of the vaccine for children 5 to 11 years old. The clinical trial data of COVID vaccine will be submitted to regulatory authorities for school-aged children before the start of the winter season, Trial results provide a strong foundation for seeking authorization of the vaccine for children 5 to 11 years old. The clinical trial data of COVID vaccine will be submitted to regulatory authorities for school-aged children before the start of the winter season, , Read More